📢BIA report published today reveals that #biotech companies on London stock markets delivered market-beating returns in 2020 and attracted new #investors looking for growth in a turbulent year.
📄 Full report: bioindustry.org/uploads/assets…
#InvestinBiotech 1/7
📄 Full report: bioindustry.org/uploads/assets…
#InvestinBiotech 1/7
The combined share price of UK-quoted biotech companies was up 155% over the year.📈
It was outperforming the #FTSE All-Share before the #pandemic hit the UK and accelerated after. 2/7
It was outperforming the #FTSE All-Share before the #pandemic hit the UK and accelerated after. 2/7
Those involved in diagnostics and #COVID19 treatments were the best performers (up 493% and 475%, respectively).🧫
Other sub-sectors including small molecule drug development (+286%), research tools and data (+153%) and cell & gene therapies (+149%) also performed well.🔬 3/7
Other sub-sectors including small molecule drug development (+286%), research tools and data (+153%) and cell & gene therapies (+149%) also performed well.🔬 3/7
£1,141m of fresh equity was raised by 51 individual companies. 💰
This is more than double the amount raised in 2018 and 2019 combined! 4/7
This is more than double the amount raised in 2018 and 2019 combined! 4/7
The sector has attracted new #investors, led by those from North America (24 new investors, net trading inflow of £649m), UK Retail Execution Only (net trading inflow of £132m) and European investors (16 new investors, net trading inflow of £52m). 5/7
Ten large UK institutions and ten smaller UK institutions have also invested in the sector for the first time. 🇬🇧 6/7
Today's analysis shows the importance of including #biotech and #healthcare in investment portfolios as part of both risk management and growth strategies. 💰🧬
#InvestinBiotech
7/7
#InvestinBiotech
7/7
• • •
Missing some Tweet in this thread? You can try to
force a refresh
